Frontiers in Genetics (Aug 2022)
Genomic study of nonsyndromic hearing loss in unaffected individuals: Frequency of pathogenic and likely pathogenic variants in a Brazilian cohort of 2,097 genomes
- Caio Robledo D’ Angioli Costa Quaio,
- Caio Robledo D’ Angioli Costa Quaio,
- Antonio Victor Campos Coelho,
- Livia Maria Silva Moura,
- Livia Maria Silva Moura,
- Rafael Lucas Muniz Guedes,
- Rafael Lucas Muniz Guedes,
- Kelin Chen,
- Jose Ricardo Magliocco Ceroni,
- Renata Moldenhauer Minillo,
- Marcel Pinheiro Caraciolo,
- Marcel Pinheiro Caraciolo,
- Rodrigo de Souza Reis,
- Rodrigo de Souza Reis,
- Bruna Mascaro Cordeiro de Azevedo,
- Maria Soares Nobrega,
- Anne Caroline Barbosa Teixeira,
- Matheus Martinelli Lima,
- Thamara Rayssa da Mota,
- Thamara Rayssa da Mota,
- Marina Cadena da Matta,
- Gabriela Borges Cherulli Colichio,
- Aline Lulho Roncalho,
- Ana Flavia Martinho Ferreira,
- Gabriela Pereira Campilongo,
- Eduardo Perrone,
- Eduardo Perrone,
- Luiza do Amaral Virmond,
- Carolina Araujo Moreno,
- Carolina Araujo Moreno,
- Joana Rosa Marques Prota,
- Joana Rosa Marques Prota,
- Marina de França,
- Murilo Castro Cervato,
- Murilo Castro Cervato,
- Tatiana Ferreira de Almeida,
- Joao Bosco de Oliveira Filho
Affiliations
- Caio Robledo D’ Angioli Costa Quaio
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Caio Robledo D’ Angioli Costa Quaio
- Instituto da Criança (Children’s Hospital), Hospital Das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
- Antonio Victor Campos Coelho
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Livia Maria Silva Moura
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Livia Maria Silva Moura
- VarsOmics, Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, SP, Brazil
- Rafael Lucas Muniz Guedes
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Rafael Lucas Muniz Guedes
- VarsOmics, Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, SP, Brazil
- Kelin Chen
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Jose Ricardo Magliocco Ceroni
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Renata Moldenhauer Minillo
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Marcel Pinheiro Caraciolo
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Marcel Pinheiro Caraciolo
- VarsOmics, Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, SP, Brazil
- Rodrigo de Souza Reis
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Rodrigo de Souza Reis
- VarsOmics, Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, SP, Brazil
- Bruna Mascaro Cordeiro de Azevedo
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Maria Soares Nobrega
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Anne Caroline Barbosa Teixeira
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Matheus Martinelli Lima
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Thamara Rayssa da Mota
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Thamara Rayssa da Mota
- Programa de Pós Graduação em Tecnologias Energéticas e Nucleares (PROTEN), UFPE, Recife, Brazil
- Marina Cadena da Matta
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Gabriela Borges Cherulli Colichio
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Aline Lulho Roncalho
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Ana Flavia Martinho Ferreira
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Gabriela Pereira Campilongo
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Eduardo Perrone
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Eduardo Perrone
- Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo, SP, Brazil
- Luiza do Amaral Virmond
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Carolina Araujo Moreno
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Carolina Araujo Moreno
- Departamento de Medicina Translacional, Área de Genética Médica e Medicina Genômica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brazil
- Joana Rosa Marques Prota
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Joana Rosa Marques Prota
- Departamento de Medicina Translacional, Área de Genética Médica e Medicina Genômica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brazil
- Marina de França
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Murilo Castro Cervato
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Murilo Castro Cervato
- VarsOmics, Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, SP, Brazil
- Tatiana Ferreira de Almeida
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- Joao Bosco de Oliveira Filho
- Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
- DOI
- https://doi.org/10.3389/fgene.2022.921324
- Journal volume & issue
-
Vol. 13
Abstract
Hearing loss (HL) is a common sensory deficit in humans and represents an important clinical and social burden. We studied whole-genome sequencing data of a cohort of 2,097 individuals from the Brazilian Rare Genomes Project who were unaffected by hearing loss to investigate pathogenic and likely pathogenic variants associated with nonsyndromic hearing loss (NSHL). We found relevant frequencies of individuals harboring these alterations: 222 heterozygotes (10.59%) for sequence variants, 54 heterozygotes (2.58%) for copy-number variants (CNV), and four homozygotes (0.19%) for sequence variants. The top five most frequent genes and their corresponding combined allelic frequencies (AF) were GJB2 (AF = 1.57%), STRC (AF = 1%), OTOA (AF = 0.69%), TMPRSS3 (AF = 0.41%), and OTOF (AF = 0.29%). The most frequent sequence variant was GJB2:c.35del (AF = 0.72%), followed by OTOA:p. (Glu787Ter) (AF = 0.61%), while the most recurrent CNV was a microdeletion of 57.9 kb involving the STRC gene (AF = 0.91%). An important fraction of these individuals (n = 104; 4.96%) presented variants associated with autosomal dominant forms of NSHL, which may imply the development of some hearing impairment in the future. Using data from the heterozygous individuals for recessive forms and the Hardy–Weinberg equation, we estimated the population frequency of affected individuals with autosomal recessive NSHL to be 1:2,222. Considering that the overall prevalence of HL in adults ranges from 4–15% worldwide, our data indicate that an important fraction of this condition may be associated with a monogenic origin and dominant inheritance.
Keywords
- nonsyndromic hearing loss
- hearing loss
- deafness
- genomics
- whole genome sequencing
- GJB2 (C×26) gene mutations